Razi Haque

Razi Haque is a Research Engineer and the Implantable Microsystems Group Leader at Lawrence Livermore National Laboratory where he serves as principal investigator for a number of externally-funded research programs from the NIH and DARPA as well as internally-funded Laboratory Directed Research Development programs. The Implantable Microsystems Group primarily focuses on building flexible devices using microfabrication techniques and tools and leverages a quality management system to build human-grade implantable devices. The Group’s research focus is on next-generation neural interfaces and integrating multi-modal capabilities, including chemical and optical interfaces. Previously, Razi worked at a startup in southern California focusing on translating his graduate studies at the University of Michigan which focused on an intraocular implantable microsystem.

Daniel Faissol

Dan Faissol is the program lead for predictive design of biologics at LLNL and leads LLNL’s initiative in deep reinforcement learning for national security applications. He currently serves on the LLNL Data Science Institute Council and as the lead for the computational and data science area within the LLNL Bioengineering Center.

Dan joined LLNL as postdoc in 2008 and served as group leader of the Operations Research and System Analysis group from 2013 to 2017. His current primary area of focus is in developing novel approaches for integrating artificial intelligence, simulation and experimental evaluations to accelerate design and scientific discovery, primarily applied to antibody and vaccine antigen design.

Dan earned his Ph.D. in Industrial and Systems Engineering at Georgia Institute of Technology, his M.S. in Economics from Georgia Institute of Technology, and his B.S. in Electrical Engineering at University of California, Los Angeles.

Doris Lam (PLS)

Doris Lam is a neuroscientist specializing in neuroimmunology. Her research interest is in understanding the interaction between different cell types in the central nervous system (CNS). Her research has used multi-disciplinary approaches (electrophysiology, and cell and molecular biology) to identify mechanisms that regulate cellular activity in CNS cells (e.g. neurons and microglia), and how they contribute to neurodegenerative diseases. Lam's current work focuses on reproducing the CNS on an in-vitro, chip-based Human Investigational Platform.

Matt Coleman (PLS)

Matt is a senior staff biomedical scientist at Lawrence Livermore National Laboratory in the division of Biology and Biotechnology and an adjunct professor in the department of Radiation Oncology at the University of California at Davis. He has authored over 120 publications in peer-reviewed journals, published proceedings and book chapters covering a diverse breadth of molecular biology and biochemistry. Matt's major areas of research focus are in the area of radiobiology in support of cancer treatment and biodosimetry. His group has also been very active in the development of biotechnology and advance biochemical techniques around the areas of cell-free expression, membrane proteins and nanoparticles made of apolipoproteins called nanolipoprotein particles (NLPs).

Nick Fischer (PLS)

Nick Fischer has been a staff scientist in the Physical and Life Sciences (PLS) Directorate at Lawrence Livermore National Laboratory since 2008. He also worked as a Postdoctoral Fellow in PLS at LLNL under PI Jeffrey Tok. Prior to his tenure at LLNL, Fischer was a Research Assistant at the University of Massachusetts, Amherst where he completed his PhD in Molecular and Cellular Biology Program (2005). Fischer earned a B.S. in Biology at West Chester University of Pennsylvania.

Nick’s research Interests include biomimetic nanoparticle design for vaccine-related in vivo applications, in vitro tissue mimetic platforms, biomimetic nanoparticle development and characterization, molecular recognition elements and detection platforms, and metal-core nanoparticles and applications.